AccuStem Sciences, Inc. (ACUT)
OTCMKTS · Delayed Price · Currency is USD
0.3757
0.00 (0.00%)
At close: Mar 20, 2026
AccuStem Sciences Market Cap
AccuStem Sciences has a market cap or net worth of $6.04 million as of March 20, 2026. Its market cap has increased by 71.61% in one year.
Market Cap
6.04M
Enterprise Value
6.07M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.38
Market Cap Chart
Since March 2, 2022, AccuStem Sciences's market cap has decreased from 20.42M to 6.04M, a decrease of -70.43%. That is a compound annual growth rate of -25.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 6.04M | -53.82% |
| Dec 31, 2025 | 13.07M | 157.22% |
| Dec 31, 2024 | 5.08M | -28.40% |
| Dec 29, 2023 | 7.10M | -53.62% |
| Dec 30, 2022 | 15.31M | -25.04% |
| Mar 2, 2022 | 20.42M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Brainstorm Cell Therapeutics | 9.74M |
| Curative Biotechnology | 8.47M |
| Synlogic | 8.36M |
| TRON Group | 8.18M |
| BetterLife Pharma | 7.40M |
| Nymox Pharmaceutical | 5.82M |
| Mosaic ImmunoEngineering | 5.01M |
| Enzon Pharmaceuticals | 4.45M |